Senators Want FDA Action on Social Media Drug Promotions

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Senators Want FDA Action on Social Media Drug Promotions

J.W. Schomisch

February 19, 2024 at 09:28 AM EST

Two U.S. senators urged the FDA to take “swift action to update its enforcement tools” regarding the promotion of prescription drugs on social media. In a letter to FDA Commissioner Dr. Robert M. Califf, Sens. Dick Durbin, D-Ill., and Mike Braun, R-Ind., observed the FDA has not updated its draft guidance on prescription drug promotion for social media since 2014. The senato... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Senators Want FDA Action on Social Media Drug Promotions

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT